Michał Mikuła

4.3k citations
135 papers · 2.7k indexed · h-index 28
Topics
RNA Research and Splicing (14 papers)RNA modifications and cancer (12 papers)Gut microbiota and health (12 papers)

In The Last Decade

Michał Mikuła

126 papers receiving 2.7k citations

Peers

Michał Mikuła
Comparison fields: 5 of 118
  • Molecular Biology 1.6k
  • Oncology 474
  • Cancer Research 471
  • Pulmonary and Respiratory Medicine 336
  • Surgery 330
Replace Mark R. Frey with:
Mark R. Frey United States
Amar B. Singh United States
Paola Izzo Italy
Fabrice Journé Belgium
François Boudreau Canada
Hiroaki Kanda Japan
Frank G. Ondrey United States
Shih‐Chi Su Taiwan
Sylvie Polak‐Charcon Israel
Rong Dong China
Michał Mikuła relative to Mark R. Frey United States Mark R. Frey's profile →
Citations per field
00.5×1.5×1.8×
Mark R. Frey · 1×
Citations per year

Countries citing papers authored by Michał Mikuła

Since Specialization
Citations

This map shows the geographic impact of Michał Mikuła's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michał Mikuła with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michał Mikuła more than expected).

Fields of papers citing papers by Michał Mikuła

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michał Mikuła. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michał Mikuła. The network helps show where Michał Mikuła may publish in the future.

Co-authorship network of co-authors of Michał Mikuła

This figure shows the co-authorship network connecting the top 25 collaborators of Michał Mikuła. A scholar is included among the top collaborators of Michał Mikuła based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michał Mikuła. Michał Mikuła is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 4
4 2
5 1
6 2
7 20
8 16
9 4
10 0
11 12
12 29
13 12
14 27
15 73
16 18
17 18
18 8
19 19
20
Isolation of Listeria from brains of ruminants with suspected rabies.
3

About Michał Mikuła

Michał Mikuła is a scholar working on Cancer Research, Oncology and Molecular Biology, having authored 135 papers that have together received 2.7k indexed citations. Recurring topics across this work include RNA Research and Splicing (14 papers), RNA modifications and cancer (12 papers) and Gut microbiota and health (12 papers). The work is most often cited by research in Cancer Research (471 citations), Molecular Biology (1.6k citations) and Oncology (474 citations). Michał Mikuła has collaborated with scholars based in Poland, United States and Hungary. Frequent co-authors include Jerzy Ostrowski, Agnieszka Paziewska, Tymon Rubel, Krzysztof Goryca, Jakub Karczmarski, Maria Kulecka, Artur Dzwonek, Michał Dadlez, Karol Bomsztyk and Dorota Jarosz. Their work appears in journals such as Nucleic Acids Research, Journal of Biological Chemistry and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026